Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inspire Medical Systems, Inc. Director's Dealing 2020

May 5, 2020

31597_dirs_2020-05-04_2d5ac8c0-dd49-4cda-a8a9-33ab2b0e8e05.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inspire Medical Systems, Inc. (INSP)
CIK: 0001609550
Period of Report: 2020-04-30

Reporting Person: Mead Dana G Jr. (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-04-30 Stock Option (right to buy) $71.66 A 3501 Acquired 2030-04-30 Common Stock (3501) Direct

Footnotes

F1: The option vests and becomes exercisable on April 30, 2021, subject to the Reporting Person's continuous service to the Issuer through such date.